Recruiting OBSERVATIONAL NCT07009717

Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

The Role Of Great Toe Strength And Its Association With The Severity Of Symptoms Of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Sponsor: University of Florida

Conditions Chemotherapy-induced Peripheral Neuropathy (CIPN) Healthy

Interventions No intervention (observational study)

Updated 4 times since 2025 Last updated: Feb 9, 2026 Started: Aug 5, 2025 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chemotherapy-induced Peripheral Neuropathy (CIPN) and Healthy, this trial is actively recruiting participants. The trial is conducted by University of Florida and has accumulated 4 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Recruiting
Sep 2025 — Feb 2026 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Aug 2025 — Sep 2025 [monthly]

Not Yet Recruiting
Jul 2025 — Aug 2025 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Florida

Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States